ALDX — ALDEYRA THERAPEUTICS INC

Ownership history in US BANCORP \DE\  ·  4 quarters on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in ALDEYRA THERAPEUTICS INC (ALDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 554 -20,582 -97.4% 0.00% $3K $5.22
2025 Q2 ADDED 21,136 +21,112 +87966.7% 0.00% $81K $3.83
2025 Q1 REDUCED 24 -5,554 -99.6% 0.00% $138 $5.75
2024 Q3 INITIATED 5,578 — — 0.00% $30K $5.39
% of Fund (quarterly)    ALDX price (monthly, adj. close)

Other funds also holding ALDX

As of 2025 Q4 — sorted by position size

Knoll Capital Management, LLC 3Y 7Y 13.01% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 1.14% ARDSLEY ADVISORY PARTNERS LP 3Y 7Y 0.82% 1492 Capital Management LLC 3Y 7Y 0.44% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.39% 683 Capital Management, LLC 3Y 7Y 0.34% AlphaCentric Advisors LLC 3Y 0.18% Palo Alto Investors LP 3Y 7Y 0.16% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.14% WOODSTOCK CORP 3Y 7Y 0.12%
← Back to US BANCORP \DE\ Holdings